Clinical Trial Update: A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating VX-670 in adults with Myotonic Dystrophy Type 1 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• VX-670

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Myotonic Dystrophy Type 1 (DM1) | Phase 1, Phase 2 | Status: RECRUITING